Employment disruption after breast cancer diagnosis and financial burden in the Sister and Two Sister Studies

Authors: Meernik C, Sandler DP, Peipins LA, Hodgson ME, Wheeler SB, Weinberg CR, Nichols HB

Category: Financial Hardship Associated with Cancer
Conference Year: 2020

Abstract Body:
Purpose: High costs of cancer care in the U.S. contribute to financial hardship and poor outcomes for cancer patients. We estimated the effect of cancer-related employment disruption on financial burden in a national sample of women diagnosed with breast cancer who were relatively financially stable and had health insurance at diagnosis. Methods: Women with breast cancer who were enrolled in the Sister Study or the Two Sister Study completed a survivorship survey in 2012. Employment disruption was defined as stopping work or working fewer hours after cancer treatment. Financial burden was defined as experiencing financial problems paying for cancer care, borrowing money or going into debt because of cancer, or filing for bankruptcy because of cancer. Prevalence ratios (PRs) and 95% confidence intervals (CIs) for financial burden related to employment disruption were estimated using Poisson regression with robust error variance, adjusted for demographic and clinical characteristics. Results: We analyzed data from women who were ≥1 year from breast cancer diagnosis who reported being employed at diagnosis (n=1605 total, n=1425 non-Hispanic White (NHW), n=79 non-Hispanic Black (NHB)). On average, women were age 50 at diagnosis (range=28-77 years) and 5 years from diagnosis at survey (range=1- 8.5 years). Most women had health insurance at diagnosis (99% NHW, 97% NHB) and an annual household income of at least $50,000/year (84% NHW, 75% NHB). Overall, 27% of women reported employment disruption after diagnosis and 21% experienced financial burden, including 16% experiencing difficulty paying for cancer care, 13% borrowing money or going into debt, and 2% filing for bankruptcy. In adjusted analyses, employment disruption was associated with a higher prevalence of financial burden (NHW PR=2.00, 95% CI: 1.62, 2.47; NHB PR=3.81, 95% CI: 1.89, 7.67). Conclusions: Women experiencing disruptions to employment after cancer diagnosis are vulnerable to financial distress related to cancer and its treatment. Our results indicate financial burden is prevalent even among women who have insurance coverage and financial resources at breast cancer diagnosis. These findings could inform sick leave and work policies which may help to limit employment disruption after cancer.

Keywords: breast cancer; financial burden; employment